# The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting

> **NCT07021443** · — · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 50 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **OTHER:** non-interventional

## Key facts

- **NCT ID:** NCT07021443
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-09
- **Primary completion:** 2023-10-26
- **Final completion:** 2025-05-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021443, "The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07021443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*